Michael Pervan

Array ( [id] => 8883591 [patent_doc_number] => 20130156775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'CHLAMYDIA TRACHOMATIS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 13/344490 [patent_app_country] => US [patent_app_date] => 2012-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6682 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13344490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312631 [patent_doc_number] => 20120189654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 13/335510 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25883 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13335510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184010 [patent_doc_number] => 20120114611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'BACTERIOPHAGE-CONTAINING THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/333684 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12904 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114611.pdf [firstpage_image] =>[orig_patent_app_number] => 13333684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10608326 [patent_doc_number] => 09328350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Recombinant mycobacterium as a vaccine' [patent_app_type] => utility [patent_app_number] => 13/996802 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 12 [patent_no_of_words] => 8266 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134453 [patent_doc_number] => 20130295167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'ENHANCED IMMUNE RESPONSE IN BOVINE SPECIES' [patent_app_type] => utility [patent_app_number] => 13/995960 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10305 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227637 [patent_doc_number] => 08633305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules' [patent_app_type] => utility [patent_app_number] => 13/297095 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 23444 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13297095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11762247 [patent_doc_number] => 09370538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Non-replicating probiotic micro-organisms protect against upper respiratory tract infections' [patent_app_type] => utility [patent_app_number] => 13/884514 [patent_app_country] => US [patent_app_date] => 2011-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8299 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003129 [patent_doc_number] => 20130224254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'NON-REPLICATING PROBIOTIC MICRO-ORGANISMS PROTECT CHILDREN AGAINST GASTROINTESTINAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/884524 [patent_app_country] => US [patent_app_date] => 2011-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8006 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094185 [patent_doc_number] => 20120082694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Recombinant Viral-Based Malaria Vaccines' [patent_app_type] => utility [patent_app_number] => 13/373224 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15012 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082694.pdf [firstpage_image] =>[orig_patent_app_number] => 13373224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8127507 [patent_doc_number] => 20120088302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Cell Culture' [patent_app_type] => utility [patent_app_number] => 13/276172 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21991 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088302.pdf [firstpage_image] =>[orig_patent_app_number] => 13276172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719832 [patent_doc_number] => 20120009167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'SOLID COMPOSITION CONTAINING BACILLUS-TYPE NON-PATHOGENIC BACTERIAL SPORES' [patent_app_type] => utility [patent_app_number] => 13/234424 [patent_app_country] => US [patent_app_date] => 2011-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3295 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009167.pdf [firstpage_image] =>[orig_patent_app_number] => 13234424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7732428 [patent_doc_number] => 20120015401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'PLASMODIUM FALCIPARUM ANTIGENS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/189765 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38711 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015401.pdf [firstpage_image] =>[orig_patent_app_number] => 13189765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669116 [patent_doc_number] => 20110318385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'ENGINEERED BOTULINUM NEUROTOXIN C1 WITH SELECTIVE SUBSTRATE SPECIFICITY' [patent_app_type] => utility [patent_app_number] => 13/167156 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8679 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10089061 [patent_doc_number] => 09125864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'OMV vaccines' [patent_app_type] => utility [patent_app_number] => 13/702949 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 33 [patent_no_of_words] => 33860 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9874998 [patent_doc_number] => 08962265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Mutant parasites for use as vaccines and platforms for screening for compounds' [patent_app_type] => utility [patent_app_number] => 13/702030 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 16145 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003127 [patent_doc_number] => 20130224252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'INTESTINE IMMUNOMODULATOR' [patent_app_type] => utility [patent_app_number] => 13/819262 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10844052 [patent_doc_number] => 08871224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Botulinum toxin therapy for skin disorders' [patent_app_type] => utility [patent_app_number] => 13/073741 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14561 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13073741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7695941 [patent_doc_number] => 20110230649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Compositions and Methods for Redox Modulated Proteins' [patent_app_type] => utility [patent_app_number] => 13/051425 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8881 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230649.pdf [firstpage_image] =>[orig_patent_app_number] => 13051425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066063 [patent_doc_number] => 20110243990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias' [patent_app_type] => utility [patent_app_number] => 13/049344 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1863 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243990.pdf [firstpage_image] =>[orig_patent_app_number] => 13049344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159768 [patent_doc_number] => 20110159030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS' [patent_app_type] => utility [patent_app_number] => 13/041042 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6096 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159030.pdf [firstpage_image] =>[orig_patent_app_number] => 13041042 [rel_patent_id] =>[rel_patent_doc_number] =>)